Basic Information
| RNALocate ID: | RLID:11004021 |
| RNA Symbol: | hsa-miR-551b-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-551b-star |
| RNA ID: | miRBase:MIMAT0004794 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004019 | Exosome | Pooled sera | 27278097 |
| RLID:11004020 | Exosome | Plasma | 23663360 |
| RLID-D:11000693 | Microvesicle | Mesenchymal stem cells | |
| RLID-D:11001565 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-551b-5p | Medulloblastoma | MNDR-E-MI-60293 |
| MNDR | hsa-miR-551b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-60294 |
| MNDR | hsa-miR-551b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-60295 |
| MNDR | hsa-miR-551b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-60296 |
| MNDR | hsa-miR-551b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-60297 |
| MNDR | hsa-miR-551b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-60298 |
| MNDR | hsa-miR-551b-5p | Prostate cancer | MNDR-E-MI-60299 |
| MNDR | hsa-miR-551b-5p | Gastric cancer | MNDR-E-MI-60300 |
| MNDR | hsa-miR-551b-5p | Lung cancer | MNDR-E-MI-60301 |
| MNDR | hsa-miR-551b-5p | Parkinson disease | MNDR-E-MI-60302 |
| MNDR | hsa-miR-551b-5p | Breast cancer | MNDR-E-MI-60303 |
| MNDR | hsa-miR-551b-5p | Pancreatic cancer | MNDR-E-MI-60304 |
| MNDR | hsa-miR-551b-5p | Melanoma | MNDR-E-MI-60305 |
| MNDR | hsa-miR-551b-5p | Colon cancer | MNDR-E-MI-60306 |
| MNDR | hsa-miR-551b-5p | Familial ovarian cancer | MNDR-E-MI-60307 |
| MNDR | hsa-miR-551b-5p | Liver cancer | MNDR-E-MI-60308 |
| MNDR | hsa-miR-551b-5p | Biliary tract cancer | MNDR-E-MI-60309 |
| MNDR | hsa-miR-551b-5p | Esophageal cancer | MNDR-E-MI-60310 |
| MNDR | hsa-miR-551b-5p | Hepatocellular carcinoma | MNDR-E-MI-60311 |
| MNDR | hsa-miR-551b-5p | Familiar ovarian carcinoma | MNDR-E-MI-60312 |
| MNDR | hsa-miR-551b-5p | Malignant pleural mesothelioma | MNDR-E-MI-60313 |
| MNDR | hsa-miR-551b-5p | Burkitt lymphoma | MNDR-E-MI-60314 |
| MNDR | hsa-miR-551b-5p | Colorectal cancer | MNDR-E-MI-60315 |
| MNDR | hsa-miR-551b-5p | Nasopharynx carcinoma | MNDR-E-MI-60316 |
| MNDR | hsa-miR-551b-5p | Nasopharyngeal cancer | MNDR-E-MI-60317 |
| MNDR | hsa-miR-551b-5p | Breast cancer her3+ negative | MNDR-E-MI-60318 |
TOP